The changing landscape of atherosclerosis
P Libby - Nature, 2021 - nature.com
Emerging evidence has spurred a considerable evolution of concepts relating to
atherosclerosis, and has called into question many previous notions. Here I review this …
atherosclerosis, and has called into question many previous notions. Here I review this …
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of …
F Mach, C Baigent, AL Catapano… - European heart …, 2020 - academic.oup.com
version of the Guidelines, which is freely available via the ESC and EAS websites and
hosted on their journals' websites (EHJ and Atherosclerosis Journal). The National Cardiac …
hosted on their journals' websites (EHJ and Atherosclerosis Journal). The National Cardiac …
Clinical review on triglycerides
U Laufs, KG Parhofer, HN Ginsberg… - European heart …, 2020 - academic.oup.com
Hypertriglyceridaemia is a common clinical problem. Epidemiologic and genetic studies
have established that triglyceride-rich lipoproteins (TRL) and their remnants as important …
have established that triglyceride-rich lipoproteins (TRL) and their remnants as important …
A modern approach to dyslipidemia
AJ Berberich, RA Hegele - Endocrine reviews, 2022 - academic.oup.com
Lipid disorders involving derangements in serum cholesterol, triglycerides, or both are
commonly encountered in clinical practice and often have implications for cardiovascular …
commonly encountered in clinical practice and often have implications for cardiovascular …
Causes and consequences of hypertriglyceridemia
CJ Packard, J Boren, MR Taskinen - Frontiers in endocrinology, 2020 - frontiersin.org
Elevations in plasma triglyceride are the result of overproduction and impaired clearance of
triglyceride-rich lipoproteins—very low-density lipoproteins (VLDL) and chylomicrons …
triglyceride-rich lipoproteins—very low-density lipoproteins (VLDL) and chylomicrons …
[HTML][HTML] Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score”
Familial chylomicronaemia syndrome (FCS) is a rare, inherited disorder characterised by
impaired clearance of triglyceride (TG)-rich lipoproteins from plasma, leading to severe …
impaired clearance of triglyceride (TG)-rich lipoproteins from plasma, leading to severe …
Pharmacological targeting of the atherogenic dyslipidemia complex: the next frontier in CVD prevention beyond lowering LDL cholesterol
Notwithstanding the effectiveness of lowering LDL cholesterol, residual CVD risk remains in
high-risk populations, including patients with diabetes, likely contributed to by non-LDL lipid …
high-risk populations, including patients with diabetes, likely contributed to by non-LDL lipid …
A comprehensive update on the chylomicronemia syndrome
RB Goldberg, A Chait - Frontiers in endocrinology, 2020 - frontiersin.org
The chylomicronemia syndrome is characterized by severe hypertriglyceridemia and fasting
chylomicronemia and predisposes affected individuals to acute pancreatitis. When due to …
chylomicronemia and predisposes affected individuals to acute pancreatitis. When due to …
Role of lipoprotein lipase in lipid metabolism
G Olivecrona - Current opinion in lipidology, 2016 - journals.lww.com
Role of lipoprotein lipase in lipid metabolism : Current Opinion in Lipidology Role of lipoprotein
lipase in lipid metabolism : Current Opinion in Lipidology Log in or Register Subscribe to …
lipase in lipid metabolism : Current Opinion in Lipidology Log in or Register Subscribe to …
Severe hypertriglyceridemia: existing and emerging therapies
WA Malick, R Do, RS Rosenson - Pharmacology & Therapeutics, 2023 - Elsevier
Severe hypertriglyceridemia (sHTG), defined as a triglyceride (TG) concentration≥ 500
mg/dL (≥ 5.7 mmol/L) is an important risk factor for acute pancreatitis. Although lifestyle …
mg/dL (≥ 5.7 mmol/L) is an important risk factor for acute pancreatitis. Although lifestyle …